Smeykal Megan has filed 18 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 32850 shares of TELA Bio, Inc. ($TELA) on February 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | A | Common Stock | 32850 | $0.00 | 69,681.0000 | 45,421,795 | 89.19% | 0.07% |
| Feb. 23, 2026 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 423 | $0.77 | 66,873.0000 | 45,421,795 | 0.63% | 0.00% |
| Feb. 21, 2026 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 1590 | $0.72 | 67,296.0000 | 45,421,795 | 2.31% | 0.00% |
| Feb. 19, 2026 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 795 | $0.80 | 68,886.0000 | 45,421,795 | 1.14% | 0.00% |
| March 31, 2025 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 96 | $1.22 | 36,831.0000 | 28,526,441 | 0.26% | 0.00% |
| Feb. 21, 2025 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 1590 | $2.72 | 37,889.0000 | 28,526,441 | 4.03% | 0.01% |
| Feb. 23, 2025 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 423 | $2.72 | 37,466.0000 | 28,526,441 | 1.12% | 0.00% |
| Feb. 24, 2025 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 539 | $2.65 | 36,927.0000 | 28,526,441 | 1.44% | 0.00% |
| Feb. 19, 2025 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | A | Common Stock | 9400 | $0.00 | 39,479.0000 | 28,526,441 | 31.25% | 0.03% |
| March 31, 2024 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 96 | $5.67 | 29,000.0000 | 22,868,663 | 0.33% | 0.00% |
| Feb. 24, 2024 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 539 | $7.07 | 29,096.0000 | 22,868,663 | 1.82% | 0.00% |
| Feb. 23, 2024 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 423 | $7.07 | 29,635.0000 | 22,868,663 | 1.41% | 0.00% |
| Feb. 21, 2024 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | A | Common Stock | 9400 | $0.00 | 30,058.0000 | 22,868,663 | 45.50% | 0.04% |
| Feb. 21, 2024 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 795 | $7.00 | 20,658.0000 | 22,868,663 | 3.71% | 0.00% |
| March 31, 2023 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 96 | $10.64 | 20,431.0000 | 16,267,678 | 0.47% | 0.00% |
| Feb. 23, 2023 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 423 | $10.50 | 21,066.0000 | 16,267,678 | 1.97% | 0.00% |
| Feb. 24, 2023 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | F | Common Stock | 539 | $11.03 | 20,527.0000 | 16,267,678 | 2.56% | 0.00% |
| Feb. 21, 2023 | TELA Bio, Inc. | $TELA | Smeykal Megan | Chief Accounting Officer | A | Common Stock | 9400 | $0.00 | 21,489.0000 | 16,267,678 | 77.76% | 0.06% |